Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-010625
Filing Date
2026-03-17
Accepted
2026-03-17 17:28:20
Documents
66
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 1067057
2 EX-23.1 ex23-1.htm EX-23.1 3021
3 EX-31.1 ex31-1.htm EX-31.1 12006
4 EX-31.2 ex31-2.htm EX-31.2 12240
5 EX-32.1 ex32-1.htm EX-32.1 4805
6 EX-32.2 ex32-2.htm EX-32.2 4996
7 GRAPHIC form10-k_001.jpg GRAPHIC 25328
8 GRAPHIC form10-k_002.jpg GRAPHIC 21179
9 GRAPHIC form10-k_003.jpg GRAPHIC 20008
10 GRAPHIC form10-k_004.jpg GRAPHIC 24049
11 GRAPHIC form10-k_005.jpg GRAPHIC 30774
12 GRAPHIC form10-k_006.jpg GRAPHIC 13328
13 GRAPHIC form10-k_007.jpg GRAPHIC 10452
14 GRAPHIC form10-k_008.jpg GRAPHIC 52870
15 GRAPHIC form10-k_009.jpg GRAPHIC 31858
16 GRAPHIC fin_001.jpg GRAPHIC 63426
  Complete submission text file 0001493152-26-010625.txt   5673469

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE telo-20251231.xsd EX-101.SCH 31921
18 XBRL CALCULATION FILE telo-20251231_cal.xml EX-101.CAL 45666
19 XBRL DEFINITION FILE telo-20251231_def.xml EX-101.DEF 140778
20 XBRL LABEL FILE telo-20251231_lab.xml EX-101.LAB 372245
21 XBRL PRESENTATION FILE telo-20251231_pre.xml EX-101.PRE 289816
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 520889
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41952 | Film No.: 26763646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)